ALEX RODRIGUEZ: Open Payments
NPI 1598166266 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,734 in 158 payments from 19 companies in 2025. Trend: 2023 $2,268 · 2024 $3,139 · 2025 $2,734
Food & beverage: $2,734
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $382 |
| UCB, Inc. | 9 | $336 |
| Janssen Biotech, Inc. | 24 | $281 |
| Galderma Laboratories, L.P. | 24 | $254 |
| Arcutis Biotherapeutics, Inc. | 25 | $253 |
| Regeneron Healthcare Solutions, Inc. | 6 | $234 |
| GENZYME CORPORATION | 7 | $167 |
| Lilly USA, LLC | 9 | $124 |
| Incyte Corporation | 5 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $106 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, Zoryve, NEMLUVIO, OPZELURA, EBGLYSS.
Industry payments across FL — which companies pay providers there.
